Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated

BackgroundInternational variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.Methods We performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Pract...

Full description

Saved in:
Bibliographic Details
Published in:Clinical Kidney Journal Vol. 13; no. 4; pp. 613 - 624
Main Authors: Wong, Michelle M Y, Tu, Charlotte, Li, Yun, Perlman, Rachel L, Pecoits-Filho, Roberto, Lopes, Antonio A, Narita, Ichiei, Reichel, Helmut, Port, Friedrich K, Sukul, Nidhi, Stengel, Benedicte, Robinson, Bruce M, Massy, Ziad A, Pisoni, Ronald L
Format: Journal Article
Language:English
Published: England Oxford University Press 01.08.2020
Subjects:
Anemia
Chronic kidney failure
Complications and side effects
Hemoglobin
Iron
Iron deficiency diseases
Kidney diseases
Original
Physiological aspects
France
Brazil
United States > US
Germany
chronic kidney disease
iron deficiency
iron supplementation
anemia
erythropoiesis-stimulating agents
ISSN:2048-8513, 2048-8505, 2048-8513
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract BackgroundInternational variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.Methods We performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). A total of 6766 participants with CKD Stages 3a–5ND from nephrology clinics in Brazil, France, Germany and the USA were included.ResultsAmong patients with anemia (hemoglobin <12 g/dL), 36–58% in Brazil, the USA and Germany had repeat hemoglobin measured and 40–61% had iron indices measured within 3 months of the index hemoglobin measurement. Anemia was more common in the USA and Brazil than in France and Germany across CKD stages. Higher ferritin and lower iron saturation (TSAT) levels were observed with lower hemoglobin levels, and higher ferritin with more advanced CKD. The proportion of anemic patients with ferritin <100 ng/mL or TSAT <20% ranged from 42% in Brazil to 53% in France and Germany, and of these patients, over 40% in Brazil, Germany and the USA, compared with 27% in France, were treated with oral or intravenous iron within 3 months after hemoglobin measurement. The proportion of patients with hemoglobin <10 g/dL treated with erythropoiesis-stimulating agents ranged from 28% in the USA to 57% in Germany.ConclusionsHemoglobin and iron stores are measured less frequently than per guidelines. Among all regions, there was a substantial proportion of anemic patients with iron deficiency who were not treated with iron, highlighting an area for practice improvement in CKD care.
AbstractList Background. International variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood. Methods. We performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). A total of 6766 participants with CKD Stages 3a-5ND from nephrology clinics in Brazil, France, Germany and the USA were included. Results. Among patients with anemia (hemoglobin <12g/dL), 36-58% in Brazil, the USA and Germany had repeat hemoglobin measured and 40-61% had iron indices measured within 3months of the index hemoglobin measurement. Anemia was more common in the USA and Brazil than in France and Germany across CKD stages. Higher ferritin and lower iron saturation (TSAT) levels were observed with lower hemoglobin levels, and higher ferritin with more advanced CKD. The proportion of anemic patients with ferritin <100 ng/mL or TSAT <20% ranged from 42% in Brazil to 53% in France and Germany, and of these patients, over 40% in Brazil, Germany and the USA, compared with 27% in France, were treated with oral or intravenous iron within 3months after hemoglobin measurement. The proportion of patients with hemoglobin <10 g/dL treated with erythropoiesis-stimulating agents ranged from 28% in the USA to 57% in Germany. Conclusions. Hemoglobin and iron stores are measured less frequently than per guidelines. Among all regions, there was a substantial proportion of anemic patients with iron deficiency who were not treated with iron, highlighting an area for practice improvement in CKD care. Keywords: anemia, chronic kidney disease, erythropoiesis-stimulating agents, iron deficiency, iron supplementation
BackgroundInternational variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.Methods We performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). A total of 6766 participants with CKD Stages 3a–5ND from nephrology clinics in Brazil, France, Germany and the USA were included.ResultsAmong patients with anemia (hemoglobin <12 g/dL), 36–58% in Brazil, the USA and Germany had repeat hemoglobin measured and 40–61% had iron indices measured within 3 months of the index hemoglobin measurement. Anemia was more common in the USA and Brazil than in France and Germany across CKD stages. Higher ferritin and lower iron saturation (TSAT) levels were observed with lower hemoglobin levels, and higher ferritin with more advanced CKD. The proportion of anemic patients with ferritin <100 ng/mL or TSAT <20% ranged from 42% in Brazil to 53% in France and Germany, and of these patients, over 40% in Brazil, Germany and the USA, compared with 27% in France, were treated with oral or intravenous iron within 3 months after hemoglobin measurement. The proportion of patients with hemoglobin <10 g/dL treated with erythropoiesis-stimulating agents ranged from 28% in the USA to 57% in Germany.ConclusionsHemoglobin and iron stores are measured less frequently than per guidelines. Among all regions, there was a substantial proportion of anemic patients with iron deficiency who were not treated with iron, highlighting an area for practice improvement in CKD care.
International variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.BACKGROUNDInternational variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.We performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). A total of 6766 participants with CKD Stages 3a-5ND from nephrology clinics in Brazil, France, Germany and the USA were included.METHODSWe performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). A total of 6766 participants with CKD Stages 3a-5ND from nephrology clinics in Brazil, France, Germany and the USA were included.Among patients with anemia (hemoglobin <12 g/dL), 36-58% in Brazil, the USA and Germany had repeat hemoglobin measured and 40-61% had iron indices measured within 3 months of the index hemoglobin measurement. Anemia was more common in the USA and Brazil than in France and Germany across CKD stages. Higher ferritin and lower iron saturation (TSAT) levels were observed with lower hemoglobin levels, and higher ferritin with more advanced CKD. The proportion of anemic patients with ferritin <100 ng/mL or TSAT <20% ranged from 42% in Brazil to 53% in France and Germany, and of these patients, over 40% in Brazil, Germany and the USA, compared with 27% in France, were treated with oral or intravenous iron within 3 months after hemoglobin measurement. The proportion of patients with hemoglobin <10 g/dL treated with erythropoiesis-stimulating agents ranged from 28% in the USA to 57% in Germany.RESULTSAmong patients with anemia (hemoglobin <12 g/dL), 36-58% in Brazil, the USA and Germany had repeat hemoglobin measured and 40-61% had iron indices measured within 3 months of the index hemoglobin measurement. Anemia was more common in the USA and Brazil than in France and Germany across CKD stages. Higher ferritin and lower iron saturation (TSAT) levels were observed with lower hemoglobin levels, and higher ferritin with more advanced CKD. The proportion of anemic patients with ferritin <100 ng/mL or TSAT <20% ranged from 42% in Brazil to 53% in France and Germany, and of these patients, over 40% in Brazil, Germany and the USA, compared with 27% in France, were treated with oral or intravenous iron within 3 months after hemoglobin measurement. The proportion of patients with hemoglobin <10 g/dL treated with erythropoiesis-stimulating agents ranged from 28% in the USA to 57% in Germany.Hemoglobin and iron stores are measured less frequently than per guidelines. Among all regions, there was a substantial proportion of anemic patients with iron deficiency who were not treated with iron, highlighting an area for practice improvement in CKD care.CONCLUSIONSHemoglobin and iron stores are measured less frequently than per guidelines. Among all regions, there was a substantial proportion of anemic patients with iron deficiency who were not treated with iron, highlighting an area for practice improvement in CKD care.
International variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood. We performed a cross-sectional analysis of anemia laboratory monitoring, prevalence and management in the prospective Chronic Kidney Disease Outcomes and Practice Patterns Study (CKDopps). A total of 6766 participants with CKD Stages 3a-5ND from nephrology clinics in Brazil, France, Germany and the USA were included. Among patients with anemia (hemoglobin <12 g/dL), 36-58% in Brazil, the USA and Germany had repeat hemoglobin measured and 40-61% had iron indices measured within 3 months of the index hemoglobin measurement. Anemia was more common in the USA and Brazil than in France and Germany across CKD stages. Higher ferritin and lower iron saturation (TSAT) levels were observed with lower hemoglobin levels, and higher ferritin with more advanced CKD. The proportion of anemic patients with ferritin <100 ng/mL or TSAT <20% ranged from 42% in Brazil to 53% in France and Germany, and of these patients, over 40% in Brazil, Germany and the USA, compared with 27% in France, were treated with oral or intravenous iron within 3 months after hemoglobin measurement. The proportion of patients with hemoglobin <10 g/dL treated with erythropoiesis-stimulating agents ranged from 28% in the USA to 57% in Germany. Hemoglobin and iron stores are measured less frequently than per guidelines. Among all regions, there was a substantial proportion of anemic patients with iron deficiency who were not treated with iron, highlighting an area for practice improvement in CKD care.
Audience Academic
Author Narita, Ichiei
Li, Yun
Massy, Ziad A
Robinson, Bruce M
Reichel, Helmut
Sukul, Nidhi
Lopes, Antonio A
Wong, Michelle M Y
Tu, Charlotte
Perlman, Rachel L
Pecoits-Filho, Roberto
Stengel, Benedicte
Port, Friedrich K
Pisoni, Ronald L
AuthorAffiliation 4 Department of Nephrology, University of Michigan , Ann Arbor, MI, USA
3 School of Public Health, University of Michigan , Ann Arbor, MI, USA
10 CESP, Center for Research in Epidemiology and Population Health, Univ Paris-Saclay, Univ Paris-Sud , UVSQ, Inserm UMRS 1018, Villejuif, France
8 Nephrological Center, Villingen-Schwenningen , Germany
6 Faculdade de Medicina da Bahia School of Medicine, Universidade Federal da Bahia , Salvador, Brazil
1 Department of Medicine, University of British Columbia , Vancouver, BC, Canada
2 Arbor Research Collaborative for Health , Ann Arbor, MI, USA
11 Division of Nephrology, Ambroise Paré University Hospital , APHP, Boulogne-Billancourt/Paris, France
5 School of Medicine, Pontificia Universidade Catolica do Parana , Curitiba, PR, Brazil
7 Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Science , Niigata, Japan
9 Department of Internal Medicine, Michigan Medicine, and Department of Epidemiology, School
AuthorAffiliation_xml – name: 9 Department of Internal Medicine, Michigan Medicine, and Department of Epidemiology, School of Public Health, University of Michigan , Ann Arbor MI, USA
– name: 4 Department of Nephrology, University of Michigan , Ann Arbor, MI, USA
– name: 5 School of Medicine, Pontificia Universidade Catolica do Parana , Curitiba, PR, Brazil
– name: 1 Department of Medicine, University of British Columbia , Vancouver, BC, Canada
– name: 6 Faculdade de Medicina da Bahia School of Medicine, Universidade Federal da Bahia , Salvador, Brazil
– name: 7 Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Science , Niigata, Japan
– name: 2 Arbor Research Collaborative for Health , Ann Arbor, MI, USA
– name: 10 CESP, Center for Research in Epidemiology and Population Health, Univ Paris-Saclay, Univ Paris-Sud , UVSQ, Inserm UMRS 1018, Villejuif, France
– name: 11 Division of Nephrology, Ambroise Paré University Hospital , APHP, Boulogne-Billancourt/Paris, France
– name: 3 School of Public Health, University of Michigan , Ann Arbor, MI, USA
– name: 8 Nephrological Center, Villingen-Schwenningen , Germany
Author_xml – sequence: 1
  givenname: Michelle M Y
  surname: Wong
  fullname: Wong, Michelle M Y
  email: mimywong@mail.ubc.ca
  organization: Department of Medicine, University of British Columbia, Vancouver, BC, Canada
– sequence: 2
  givenname: Charlotte
  surname: Tu
  fullname: Tu, Charlotte
  organization: Arbor Research Collaborative for Health, Ann Arbor, MI, USA
– sequence: 3
  givenname: Yun
  surname: Li
  fullname: Li, Yun
  organization: School of Public Health, University of Michigan, Ann Arbor, MI, USA
– sequence: 4
  givenname: Rachel L
  surname: Perlman
  fullname: Perlman, Rachel L
  organization: Department of Nephrology, University of Michigan, Ann Arbor, MI, USA
– sequence: 5
  givenname: Roberto
  surname: Pecoits-Filho
  fullname: Pecoits-Filho, Roberto
  organization: Department of Medicine, University of British Columbia, Vancouver, BC, Canada
– sequence: 6
  givenname: Antonio A
  surname: Lopes
  fullname: Lopes, Antonio A
  organization: Faculdade de Medicina da Bahia School of Medicine, Universidade Federal da Bahia, Salvador, Brazil
– sequence: 7
  givenname: Ichiei
  surname: Narita
  fullname: Narita, Ichiei
  organization: Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Science, Niigata, Japan
– sequence: 8
  givenname: Helmut
  surname: Reichel
  fullname: Reichel, Helmut
  organization: Nephrological Center, Villingen-Schwenningen, Germany
– sequence: 9
  givenname: Friedrich K
  surname: Port
  fullname: Port, Friedrich K
  organization: Arbor Research Collaborative for Health, Ann Arbor, MI, USA
– sequence: 10
  givenname: Nidhi
  surname: Sukul
  fullname: Sukul, Nidhi
  organization: Department of Nephrology, University of Michigan, Ann Arbor, MI, USA
– sequence: 11
  givenname: Benedicte
  surname: Stengel
  fullname: Stengel, Benedicte
  organization: CESP, Center for Research in Epidemiology and Population Health, Univ Paris-Saclay, Univ Paris-Sud, UVSQ, Inserm UMRS 1018, Villejuif, France
– sequence: 12
  givenname: Bruce M
  surname: Robinson
  fullname: Robinson, Bruce M
  organization: Arbor Research Collaborative for Health, Ann Arbor, MI, USA
– sequence: 13
  givenname: Ziad A
  surname: Massy
  fullname: Massy, Ziad A
  organization: CESP, Center for Research in Epidemiology and Population Health, Univ Paris-Saclay, Univ Paris-Sud, UVSQ, Inserm UMRS 1018, Villejuif, France
– sequence: 14
  givenname: Ronald L
  surname: Pisoni
  fullname: Pisoni, Ronald L
  organization: Arbor Research Collaborative for Health, Ann Arbor, MI, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32905241$$D View this record in MEDLINE/PubMed
BookMark eNp9kt9u0zAYxS00xEbZDQ-ALCEkhOhmx3Zjc4FUbfwTE5sEXFuu86X1ltjFdiaVK96Bd-GBeBJctYNtmogvkji_c-wTn4doxwcPCD2m5IASxQ7txflhar8TRe-hvYpwOZaCsp1rz7toP6VzUq7yRrh4gHZZpYioON1Dv6Yeemew8Q12MXjcQOusA29X2PTBz7FdlGln8YVrPKxw4xKYBPhzNnNImP3-8VN8OsZLk4soJ-w8zgvAR1vVx43qeKs6HbINfdGt1zuLxmZnAZ-ZnCH6VEyHZvUKhzaDx4Pvi2aI0LzElyY6M-tWOEcwGZpH6H5rugT72_sIfX375svR-_HJ6bsPR9OTseVK5TFvoWayLb-C1KY2wnA-I4pUjEkhGRdqZiXllElKmQJTSyaNBCENEbaZGcVG6PXGdznMemhsiRhNp5fR9SaudDBO3_zi3ULPw6Wu-aQWxW-Enm8NYvg2QMq6d8lC1xkPYUi64pxOyESWLY3Q01voeRiiL_E0oxMlVMVV_Y-amw60820o69q1qZ5OuCB1xURVqIM7qDKactq2NKh1Zf6G4Mn1oH8TXjWlAGQD2BhSitBq63I59LDO7TpNiV73UZc-6k0fi-TFLcmV653wsw0chuX_uD9J0PAt
CitedBy_id crossref_primary_10_1016_j_transci_2021_103139
crossref_primary_10_2147_IJNRD_S291393
crossref_primary_10_1007_s10157_021_02137_1
crossref_primary_10_3390_jcm9082429
crossref_primary_10_1007_s40620_020_00699_z
crossref_primary_10_1371_journal_pone_0277921
crossref_primary_10_3390_biomedicines12081884
crossref_primary_10_3389_fendo_2024_1342873
crossref_primary_10_1111_sdi_13249
crossref_primary_10_7759_cureus_70114
crossref_primary_10_1016_j_ajt_2024_03_017
crossref_primary_10_1186_s12882_024_03849_8
crossref_primary_10_1016_j_nephro_2022_10_003
crossref_primary_10_1681_ASN_2020101531
crossref_primary_10_1093_ndt_gfad096
crossref_primary_10_1186_s12882_022_02778_8
crossref_primary_10_1007_s11255_020_02663_z
crossref_primary_10_2147_IJNRD_S474716
crossref_primary_10_1038_s41598_023_45580_8
crossref_primary_10_1093_ndt_gfab191
crossref_primary_10_1093_ndt_gfac165
crossref_primary_10_1093_ckj_sfad143
crossref_primary_10_1186_s12882_021_02491_y
crossref_primary_10_1080_14740338_2021_1853098
crossref_primary_10_1093_ndt_gfad235
crossref_primary_10_1093_ckj_sfac240
crossref_primary_10_1093_ckj_sfae269
crossref_primary_10_1038_s41598_022_10717_8
crossref_primary_10_1016_j_ejim_2025_106506
crossref_primary_10_1016_j_xkme_2023_100666
crossref_primary_10_1016_j_xkme_2023_100667
crossref_primary_10_1007_s10557_022_07321_3
crossref_primary_10_1161_JAHA_124_037363
crossref_primary_10_2147_IJNRD_S401598
crossref_primary_10_3390_jcm11195820
crossref_primary_10_1007_s40620_023_01849_9
crossref_primary_10_1093_ckj_sfac004
crossref_primary_10_1007_s10157_025_02761_1
crossref_primary_10_3390_nu16131978
crossref_primary_10_1016_j_xkme_2023_100677
crossref_primary_10_1080_0886022X_2023_2290926
crossref_primary_10_1186_s12882_020_01912_8
crossref_primary_10_3390_jcm14155575
crossref_primary_10_1007_s00726_025_03451_8
crossref_primary_10_3389_fmed_2020_565135
crossref_primary_10_1111_nep_70002
crossref_primary_10_1007_s40620_024_01937_4
crossref_primary_10_1016_j_kint_2021_03_020
crossref_primary_10_1177_00185787241267730
crossref_primary_10_3390_healthcare13111317
crossref_primary_10_3389_fphys_2021_619054
crossref_primary_10_1186_s12937_025_01072_1
crossref_primary_10_1016_j_ekir_2025_01_029
crossref_primary_10_1093_ndt_gfab050
crossref_primary_10_3390_ijms22031008
crossref_primary_10_1007_s12325_022_02367_z
crossref_primary_10_33393_grhta_2024_3062
crossref_primary_10_3389_fmed_2025_1529280
crossref_primary_10_1186_s12882_023_03440_7
crossref_primary_10_1007_s40620_024_02162_9
crossref_primary_10_1055_a_2511_0543
crossref_primary_10_3389_fphar_2021_795214
crossref_primary_10_3390_toxins14020127
crossref_primary_10_1177_03000605211030124
crossref_primary_10_1371_journal_pone_0287859
crossref_primary_10_1155_2023_8720293
crossref_primary_10_1681_ASN_2020081150
crossref_primary_10_1177_20543581211063984
crossref_primary_10_2147_IJNRD_S248075
crossref_primary_10_3390_ijms24065315
crossref_primary_10_1016_j_nephro_2021_12_003
crossref_primary_10_1093_ndt_gfae075
crossref_primary_10_1016_j_nephro_2022_03_001
crossref_primary_10_3389_fmed_2021_642296
crossref_primary_10_1093_ckj_sfaf252
crossref_primary_10_34067_KID_0000000000000204
crossref_primary_10_1093_ckj_sfad152
crossref_primary_10_1093_ckj_sfac023
Cites_doi 10.1111/nep.12493
10.1172/JCI110154
10.2215/CJN.01070308
10.1186/s41100-017-0114-y
10.1053/j.ajkd.2016.03.414
10.1093/ndt/gfv297
10.1038/ki.2009.551
10.1093/ndt/gft388
10.1681/ASN.2008020159
10.1185/030079904X2763
10.1681/ASN.2011111078
10.5301/ijao.5000204
10.1053/j.ajkd.2009.10.043
10.1038/ki.1984.36
10.1053/j.ajkd.2013.06.008
10.1016/j.ahj.2005.03.055
10.2215/CJN.01390406
10.1681/ASN.2014080842
10.1093/ndt/18.1.89
10.1093/ndt/gfu201
10.1186/s12882-018-0861-1
10.1038/ki.2015.163
10.1111/j.1744-9987.2012.01089.x
10.1056/NEJMoa062276
10.1161/CIRCULATIONAHA.105.549121
10.2215/CJN.00080116
10.2215/CJN.01670408
10.1097/00007890-199709270-00021
10.1038/ki.2013.252
10.1001/archinte.162.12.1401
10.1093/ndt/gfw123.05
10.1172/JCI118484
10.1371/journal.pone.0084144
10.1056/NEJMoa065485
10.1056/NEJM199301213280304
10.1111/j.1365-2125.1992.tb05644.x
10.1016/j.kint.2015.10.002
10.1093/ndt/gft033
10.1093/ndt/gft021
10.1172/JCI110505
10.1172/JCI119769
10.1053/j.ajkd.2009.12.030
10.1056/NEJMoa0907845
ContentType Journal Article
Copyright The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. 2019
The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.
COPYRIGHT 2020 Oxford University Press
The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. 2019
– notice: The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.
– notice: COPYRIGHT 2020 Oxford University Press
– notice: The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA. This work is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
CorporateAuthor the CKDopps Investigators
CKDopps Investigators
CorporateAuthor_xml – name: the CKDopps Investigators
– name: CKDopps Investigators
DBID TOX
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1093/ckj/sfz091
DatabaseName Oxford Journals Open Access Collection
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
Publicly Available Content Database
MEDLINE - Academic
PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: TOX
  name: Oxford Journals Open Access Collection
  url: https://academic.oup.com/journals/
  sourceTypes: Publisher
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2048-8513
EndPage 624
ExternalDocumentID PMC7467578
A645072352
32905241
10_1093_ckj_sfz091
10.1093/ckj/sfz091
Genre Journal Article
GeographicLocations France
Brazil
United States--US
Germany
GeographicLocations_xml – name: France
– name: Germany
– name: United States--US
– name: Brazil
GroupedDBID TOX
0R~
5VS
7X7
8FI
8FJ
AAFWJ
AAMVS
AAPXW
AAVAP
AAYXX
ABDBF
ABEJV
ABGNP
ABKDP
ABNKS
ABOCM
ABPTD
ABUWG
ABXVV
ABZBJ
ACGFS
ACUHS
ADBBV
ADEYI
ADHZD
ADOCK
AEGXH
AENZO
AFFHD
AFKRA
AFPKN
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AMNDL
AOIJS
BAYMD
BCNDV
BENPR
CCPQU
CIDKT
CITATION
D~K
EBS
EE~
F9B
FYUFA
GROUPED_DOAJ
H13
H5~
HMCUK
HYE
HZ~
IAO
IHR
INH
ITC
KQ8
KSI
M48
OAWHX
OJQWA
OK1
PEELM
PHGZM
PHGZT
PIMPY
Q1.
ROL
RPM
RW1
RXO
TJX
UKHRP
4.4
53G
AAPPN
ADRAZ
AFULF
BTTYL
EJD
J21
M49
M~E
NPM
ROX
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c499t-4fe738f20407a7a5a44b0902338583459bc8141381139ea7838a8e58a05cdba93
IEDL.DBID BENPR
ISICitedReferencesCount 95
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000577244700015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2048-8513
2048-8505
IngestDate Tue Nov 04 01:47:52 EST 2025
Fri Sep 05 08:16:00 EDT 2025
Tue Oct 07 07:18:13 EDT 2025
Tue Nov 11 07:36:26 EST 2025
Tue Nov 04 17:55:10 EST 2025
Wed Feb 19 02:27:26 EST 2025
Sat Nov 29 05:39:11 EST 2025
Tue Nov 18 22:22:00 EST 2025
Tue Nov 19 12:02:20 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords chronic kidney disease
iron deficiency
iron supplementation
anemia
erythropoiesis-stimulating agents
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
http://creativecommons.org/licenses/by-nc/4.0
The Author(s) 2019. Published by Oxford University Press on behalf of ERA-EDTA.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c499t-4fe738f20407a7a5a44b0902338583459bc8141381139ea7838a8e58a05cdba93
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
See Acknowledgements section for CKDopps Investigators.
OpenAccessLink https://www.proquest.com/docview/3169592497?pq-origsite=%requestingapplication%
PMID 32905241
PQID 3169592497
PQPubID 7089197
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7467578
proquest_miscellaneous_2441606823
proquest_journals_3169592497
gale_infotracmisc_A645072352
gale_infotracacademiconefile_A645072352
pubmed_primary_32905241
crossref_citationtrail_10_1093_ckj_sfz091
crossref_primary_10_1093_ckj_sfz091
oup_primary_10_1093_ckj_sfz091
PublicationCentury 2000
PublicationDate 2020-08-01
PublicationDateYYYYMMDD 2020-08-01
PublicationDate_xml – month: 08
  year: 2020
  text: 2020-08-01
  day: 01
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Oxford
PublicationTitle Clinical Kidney Journal
PublicationTitleAlternate Clin Kidney J
PublicationYear 2020
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References Iimori (2020101306144558000_sfz091-B6) 2015; 20
Patel (2020101306144558000_sfz091-B16) 2010; 77
2020101306144558000_sfz091-B28
Drueke (2020101306144558000_sfz091-B44) 2006; 355
Negri (2020101306144558000_sfz091-B39) 2014; J8
Locatelli (2020101306144558000_sfz091-B25) 2013; 28
Pfeffer (2020101306144558000_sfz091-B45) 2009; 361
Kalantar-Zadeh (2020101306144558000_sfz091-B34) 2006; 1
Mariani (2020101306144558000_sfz091-B29) 2016; 68
St. Peter (2020101306144558000_sfz091-B41) 2018; 19
McClellan (2020101306144558000_sfz091-B3) 2004; 20
(2020101306144558000_sfz091-B23) 2015
Bogin (2020101306144558000_sfz091-B12) 1982; 69
Morrone (2020101306144558000_sfz091-B17) 1997; 64
Kliger (2020101306144558000_sfz091-B26) 2013; 62
Stancu (2020101306144558000_sfz091-B32) 2010; 55
Umanath (2020101306144558000_sfz091-B38) 2015; 26
McGonigle (2020101306144558000_sfz091-B7) 1984; 25
Agarwal (2020101306144558000_sfz091-B37) 2015; 88
Matos (2020101306144558000_sfz091-B43) 2013; 36
Macdougall (2020101306144558000_sfz091-B36) 2014; 29
Rambod (2020101306144558000_sfz091-B10) 2008; 3
Mercadal (2020101306144558000_sfz091-B31) 2014; 9
Moranne (2020101306144558000_sfz091-B1) 2009; 20
Tran (2020101306144558000_sfz091-B11) 2015; 31
Rao (2020101306144558000_sfz091-B13) 1993; 328
Babitt (2020101306144558000_sfz091-B9) 2010; 55
Icardi (2020101306144558000_sfz091-B15) 2013; 28
Stengel (2020101306144558000_sfz091-B30) 2014; 29
Macdougall (2020101306144558000_sfz091-B35) 2016; 89
Astor (2020101306144558000_sfz091-B4) 2006; 151
Azizi (2020101306144558000_sfz091-B21) 1996; 97
de Benoist (2020101306144558000_sfz091-B27) 2008
Fishbane (2020101306144558000_sfz091-B33) 2009; 4
Babitt (2020101306144558000_sfz091-B5) 2012; 23
Pratt (2020101306144558000_sfz091-B18) 1992; 34
(2020101306144558000_sfz091-B48) 2018
Meytes (2020101306144558000_sfz091-B14) 1981; 67
Mrug (2020101306144558000_sfz091-B19) 1997; 100
Locatelli (2020101306144558000_sfz091-B47) 2016; 11
Astor (2020101306144558000_sfz091-B2) 2002; 162
Wong (2020101306144558000_sfz091-B42); 31
Valderrábano (2020101306144558000_sfz091-B40) 2003; 18
van der Meer (2020101306144558000_sfz091-B20) 2005; 112
Singh (2020101306144558000_sfz091-B46) 2006; 355
(2020101306144558000_sfz091-B22) 2012; 2
Yamamoto (2020101306144558000_sfz091-B24) 2017; 3
Robinson (2020101306144558000_sfz091-B49) 2014; 85
Sato (2020101306144558000_sfz091-B8) 2012; 16
References_xml – volume: 20:
  start-page: 601–608
  year: 2015
  ident: 2020101306144558000_sfz091-B6
  article-title: Anaemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: the CKD-ROUTE study
  publication-title: Nephrology
  doi: 10.1111/nep.12493
– volume: 67
  start-page: 1263
  year: 1981
  ident: 2020101306144558000_sfz091-B14
  article-title: Effect of parathyroid hormone on erythropoiesis
  publication-title: J Clin Invest
  doi: 10.1172/JCI110154
– volume: 3
  start-page: 1691
  year: 2008
  ident: 2020101306144558000_sfz091-B10
  article-title: Combined high serum ferritin and low iron saturation in hemodialysis patients: the role of inflammation
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01070308
– volume: 3
  start-page: 36
  year: 2017
  ident: 2020101306144558000_sfz091-B24
  article-title: 2015 Japanese society for dialysis therapy: guidelines for renal anemia in chronic kidney disease
  publication-title: Renal Replacement Therapy
  doi: 10.1186/s41100-017-0114-y
– volume: 68
  start-page: 402
  year: 2016
  ident: 2020101306144558000_sfz091-B29
  article-title: The CKD outcomes and practice patterns study (CKDopps): rationale and methods
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2016.03.414
– volume: 31
  start-page: 636
  year: 2015
  ident: 2020101306144558000_sfz091-B11
  article-title: Serum phosphorus and association with anemia among a large diverse population with and without chronic kidney disease
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfv297
– volume: 77
  start-page: 715
  year: 2010
  ident: 2020101306144558000_sfz091-B16
  article-title: Vitamin D deficiency and anemia in early chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1038/ki.2009.551
– year: 2015
  ident: 2020101306144558000_sfz091-B23
– volume: 29
  start-page: 1500
  year: 2014
  ident: 2020101306144558000_sfz091-B30
  article-title: The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft388
– volume: 20:
  start-page: 164
  year: 2009
  ident: 2020101306144558000_sfz091-B1
  article-title: Timing of onset of CKD-related metabolic complications
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2008020159
– volume: 20:
  start-page: 1501
  year: 2004
  ident: 2020101306144558000_sfz091-B3
  article-title: The prevalence of anemia in patients with chronic kidney disease
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079904X2763
– volume: 23
  start-page: 1631
  year: 2012
  ident: 2020101306144558000_sfz091-B5
  article-title: Mechanisms of anemia in CKD
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2011111078
– volume: 36
  start-page: 640
  year: 2013
  ident: 2020101306144558000_sfz091-B43
  article-title: Prevalence and management of anemia in hemodialysis patients in a Brazilian population of predominantly African descent
  publication-title: Int J Artif Organs
  doi: 10.5301/ijao.5000204
– volume: 55
  start-page: 639
  year: 2010
  ident: 2020101306144558000_sfz091-B32
  article-title: Bone marrow iron, iron indices, and the response to intravenous iron in patients with non–dialysis-dependent CKD
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2009.10.043
– volume: 25
  start-page: 437
  year: 1984
  ident: 2020101306144558000_sfz091-B7
  article-title: Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency
  publication-title: Kidney Int
  doi: 10.1038/ki.1984.36
– volume: 62
  start-page: 849
  year: 2013
  ident: 2020101306144558000_sfz091-B26
  article-title: KDOQI US commentary on the 2012 KDIGO clinical practice guideline for anemia in CKD
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2013.06.008
– volume: 151
  start-page: 492
  year: 2006
  ident: 2020101306144558000_sfz091-B4
  article-title: Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study
  publication-title: Am Heart J
  doi: 10.1016/j.ahj.2005.03.055
– volume: 1
  start-page: S9
  year: 2006
  ident: 2020101306144558000_sfz091-B34
  article-title: The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01390406
– volume: 26
  start-page: 2578
  year: 2015
  ident: 2020101306144558000_sfz091-B38
  article-title: Ferric citrate reduces intravenous iron and erythropoiesis-stimulating agent use in ESRD
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2014080842
– volume: 18
  start-page: 89–100
  year: 2003
  ident: 2020101306144558000_sfz091-B40
  article-title: PRE-dialysis survey on anaemia management
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/18.1.89
– volume: 29
  start-page: 2075
  year: 2014
  ident: 2020101306144558000_sfz091-B36
  article-title: FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gfu201
– volume: 19
  start-page: 67
  year: 2018
  ident: 2020101306144558000_sfz091-B41
  article-title: Prevalence, treatment patterns, and healthcare resource utilization in Medicare and commercially insured non-dialysis dependent chronic kidney disease patients with and without anemia in the United States
  publication-title: BMC Nephrol
  doi: 10.1186/s12882-018-0861-1
– volume: 88
  start-page: 905
  year: 2015
  ident: 2020101306144558000_sfz091-B37
  article-title: A randomized trial of intravenous and oral iron in chronic kidney disease
  publication-title: Kidney Int
  doi: 10.1038/ki.2015.163
– ident: 2020101306144558000_sfz091-B28
– volume: 16
  start-page: 522–528
  year: 2012
  ident: 2020101306144558000_sfz091-B8
  article-title: Shortened red blood cell lifespan is related to the dose of erythropoiesis-stimulating agents requirement in patients on hemodialysis
  publication-title: Ther Apher Dial
  doi: 10.1111/j.1744-9987.2012.01089.x
– volume: 2
  start-page: 279
  year: 2012
  ident: 2020101306144558000_sfz091-B22
  article-title: KDIGO clinical practice guideline for anemia in chronic kidney disease
  publication-title: Kidney Int Suppl
– volume: 355
  start-page: 2071
  year: 2006
  ident: 2020101306144558000_sfz091-B44
  article-title: Normalization of hemoglobin level in patients with chronic kidney disease and anemia
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa062276
– volume: 112
  start-page: 1743
  year: 2005
  ident: 2020101306144558000_sfz091-B20
  article-title: Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.105.549121
– volume: 11
  start-page: 1269
  year: 2016
  ident: 2020101306144558000_sfz091-B47
  article-title: Iron therapy challenges for the treatment of nondialysis CKD patients
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.00080116
– volume: 4
  start-page: 57
  year: 2009
  ident: 2020101306144558000_sfz091-B33
  article-title: Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988–2004
  publication-title: Clin J Am Soc Nephrol
  doi: 10.2215/CJN.01670408
– volume: 64
  start-page: 913
  year: 1997
  ident: 2020101306144558000_sfz091-B17
  article-title: Interference of angiotensin-converting enzyme inhibitors on erythropoiesis in kidney transplant recipients: role of growth factors and cytokines1
  publication-title: . Transplant
  doi: 10.1097/00007890-199709270-00021
– volume: 85
  start-page: 158
  year: 2014
  ident: 2020101306144558000_sfz091-B49
  article-title: Worldwide, mortality risk is high soon after initiation of hemodialysis
  publication-title: Kidney Int
  doi: 10.1038/ki.2013.252
– volume: 162
  start-page: 1401
  year: 2002
  ident: 2020101306144558000_sfz091-B2
  article-title: Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994)
  publication-title: Arch Intern Med
  doi: 10.1001/archinte.162.12.1401
– volume: 31
  start-page: i16
  ident: 2020101306144558000_sfz091-B42
  article-title: Anemia prevalence and treatment among patients with chronic kidney disease stage 3-5: data from the chronic kidney disease outcomes and practice patterns study (CKDOPPS)
  publication-title: Nephrol Dialysis Transplant 2016
  doi: 10.1093/ndt/gfw123.05
– volume: 97
  start-page: 839
  year: 1996
  ident: 2020101306144558000_sfz091-B21
  article-title: Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline
  publication-title: J Clin Invest
  doi: 10.1172/JCI118484
– year: 2008
  ident: 2020101306144558000_sfz091-B27
– volume: 9
  start-page: e84144
  year: 2014
  ident: 2020101306144558000_sfz091-B31
  article-title: A 3-marker index improves the identification of iron disorders in CKD anaemia
  publication-title: PloS One
  doi: 10.1371/journal.pone.0084144
– volume: 355
  start-page: 2085
  year: 2006
  ident: 2020101306144558000_sfz091-B46
  article-title: Correction of anemia with epoetin alfa in chronic kidney disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa065485
– volume: 328
  start-page: 171
  year: 1993
  ident: 2020101306144558000_sfz091-B13
  article-title: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia
  publication-title: N Engl J Med
  doi: 10.1056/NEJM199301213280304
– year: 2018
  ident: 2020101306144558000_sfz091-B48
– volume: 34
  start-page: 363
  year: 1992
  ident: 2020101306144558000_sfz091-B18
  article-title: Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers
  publication-title: Br J Clin Pharmacol
  doi: 10.1111/j.1365-2125.1992.tb05644.x
– volume: 89
  start-page: 28
  year: 2016
  ident: 2020101306144558000_sfz091-B35
  article-title: Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
  publication-title: Kidney Int
  doi: 10.1016/j.kint.2015.10.002
– volume: 28
  start-page: 1346
  year: 2013
  ident: 2020101306144558000_sfz091-B25
  article-title: Kidney Disease: Improving Global Outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft033
– volume: 28
  start-page: 1672
  year: 2013
  ident: 2020101306144558000_sfz091-B15
  article-title: Renal anaemia and EPO hyporesponsiveness associated with vitamin D deficiency: the potential role of inflammation
  publication-title: Nephrol Dial Transplant
  doi: 10.1093/ndt/gft021
– volume: J8
  start-page: 161
  year: 2014
  ident: 2020101306144558000_sfz091-B39
  article-title: Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
  publication-title: Clin Kidney
– volume: 69
  start-page: 1017
  year: 1982
  ident: 2020101306144558000_sfz091-B12
  article-title: Effect of parathyroid hormone on osmotic fragility of human erythrocytes
  publication-title: J Clin Invest
  doi: 10.1172/JCI110505
– volume: 100
  start-page: 2310
  year: 1997
  ident: 2020101306144558000_sfz091-B19
  article-title: Angiotensin II stimulates proliferation of normal early erythroid progenitors
  publication-title: J Clin Invest
  doi: 10.1172/JCI119769
– volume: 55
  start-page: 726
  year: 2010
  ident: 2020101306144558000_sfz091-B9
  article-title: Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD
  publication-title: Am J Kidney Dis
  doi: 10.1053/j.ajkd.2009.12.030
– volume: 361
  start-page: 2019
  year: 2009
  ident: 2020101306144558000_sfz091-B45
  article-title: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease
  publication-title: N Engl J Med
  doi: 10.1056/NEJMoa0907845
SSID ssj0000851045
Score 2.4933388
Snippet BackgroundInternational variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.Methods We performed a...
International variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood. We performed a cross-sectional...
Background. International variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood. Methods. We performed a...
International variation in anemia assessment and management practices in chronic kidney disease (CKD) is poorly understood.BACKGROUNDInternational variation in...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
oup
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 613
SubjectTerms Anemia
Chronic kidney failure
Complications and side effects
Hemoglobin
Iron
Iron deficiency diseases
Kidney diseases
Original
Physiological aspects
Title Anemia and iron deficiency among chronic kidney disease Stages 3–5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: often unmeasured, variably treated
URI https://www.ncbi.nlm.nih.gov/pubmed/32905241
https://www.proquest.com/docview/3169592497
https://www.proquest.com/docview/2441606823
https://pubmed.ncbi.nlm.nih.gov/PMC7467578
Volume 13
WOSCitedRecordID wos000577244700015&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ : Directory of Open Access Journals [open access]
  customDbUrl:
  eissn: 2048-8513
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000851045
  issn: 2048-8513
  databaseCode: DOA
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVASL
  databaseName: Oxford Journals Open Access Collection
  customDbUrl:
  eissn: 2048-8513
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000851045
  issn: 2048-8513
  databaseCode: TOX
  dateStart: 20120201
  isFulltext: true
  titleUrlDefault: https://academic.oup.com/journals/
  providerName: Oxford University Press
– providerCode: PRVPQU
  databaseName: Download PDF from ProQuest Central
  customDbUrl:
  eissn: 2048-8513
  dateEnd: 20241208
  omitProxy: false
  ssIdentifier: ssj0000851045
  issn: 2048-8513
  databaseCode: BENPR
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2048-8513
  dateEnd: 20241208
  omitProxy: false
  ssIdentifier: ssj0000851045
  issn: 2048-8513
  databaseCode: 7X7
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2048-8513
  dateEnd: 20241208
  omitProxy: false
  ssIdentifier: ssj0000851045
  issn: 2048-8513
  databaseCode: PIMPY
  dateStart: 20080101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fb9MwELdYhxAv_B8ESmUEEkIialIntc0LKmwTCK2L0JDKU-TYDpRt7ljaSeWJ78B34QPxSbhL3LIgtBdeKkX-W-Vy9_Pd-XeEPCm0kdwoEZYJN2ESKxmKYihDY2JhrSjihOu62AQfj8VkIjPvcKt8WuVKJ9aK2sw0-sj7LB7KFA8L_OXJ1xCrRmF01ZfQ2CCbyFSWdMjmq51x9n7tZUFAEdWVipGgNhRg71ccpZL19eGXflV-i2TcskpeN7cuvJ3DnX-nT56zR7vX__ef3CDXPBKlo0Z0bpJL1t0iV_Z8rP02-Tly9niqqHKG4l04aiyyTeBVTVqXKKK6Idalh1Pj7JL6WA8F_PrJVpT9-v4jHW9Tz9xa0amjgDapp-Ol75pR237U_mIO24dxuF7m727RrKb_dBXFfMflCwpGwzq6cMeNa9M8p2dw2FfF0ZLWKfPW3CEfdncOXr8JfZWHUMNpax4mpeVMlPB-Iq64SlWSFJgsyjBkyZJUFlrEYGpFDGDVKi6YUMKmQkWpNoWSbIt03MzZe4QaAHNFbMDsyzJJ0qiAqZGgnquCK1amAXm2esu59hToWInjKG9C8SwHicgbiQjI43Xfk4b445-9nqKw5KgNYCat_KUG2A_yauWjIWyDDwDlBqTb6glfsW4190DcLlypu5Km3KuZKv8jSgF5tG7GqTF1ztnZosoBv8VwShUDFpC7jeCul2EDGaWA4QLCWyK97oDk4-0WN_1ck5BjmRrQ9vcv3tYDcnWADoo6Y7JLOvPThX1ILuuz-bQ67ZENPuH1r-j5L7dXO0XgKXu7l32Ep4P9yW8Lt1PB
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3LbhMxFLWqFAEb3o-BUIwAISRGmWfsQUIoIlSN0oQsilRWg8f2QGjrlE5SFFb8A__Bkg_iS7h3xhM6CHXXBWt7bMtzfH1s33suIY8yqRKmBHfziCk38kXi8qybuEr5XGue-RGTZbIJNh7z3d1kskZ-1LEw6FZZ28TSUKuZxDvyTuh3kxgPC-zl4WcXs0bh62qdQqOCxVAvv8CRrXgx6MP_fRwEm693Xm25NquAK4Hdz90o1yzkeQDoZYKJWERRhs6JIT6RhVGcZJL7YNq5D-RIC8ZDLriOufBiqTKB4ktg8tcjADtvkfXJYDR5t7rVQQLjlZmRURDX5cAvak3UJOzIvU-dIv_qJX5jF7R7QSPA7gTP_dtd88T-t3n5f5u5K-SSZdq0Vy2Nq2RNm2vk_Mj6ElwnP3tGH0wFFUZRjPWjSqOaBoai0jIFE5WVcDDdmyqjl9S-ZVHg5x90QcNf377H4z61yrQFnRoKbJpauWE6rL7q26_eLOYwXfAd9jexsWl0UsqbmoKiP-fyOYVNURu6MAfV1a16Ro8FmIhsf0nLkACtbpC3ZzJrN0nLzIy-TagCspr5CmhNkkdR7GXQNArwM5ExEeaxQ57WqEqllXjHTCP7aeVqEKaAwLRCoEMeruoeVsIm_6z1BMGZorWDlqSwQRswHtQNS3tdGAYLgMU7pN2oCVZKNoo3AN6n9tSu0ZtaM1qkf6DrkAerYmwaXQONni2KFPipD6dwHoQOuVUtlFU3YZB4MXBUh7DGElpVQHH1ZomZfixF1jEND-xmd04f1n1yYWtntJ1uD8bDu-RigJcxpXdom7TmRwt9j5yTx_NpcbRhLQUl7896if0GLJGnxQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Anemia+and+iron+deficiency+among+chronic+kidney+disease+Stages+3%E2%80%935ND+patients+in+the+Chronic+Kidney+Disease+Outcomes+and+Practice+Patterns+Study%3A+often+unmeasured%2C+variably+treated&rft.jtitle=Clinical+kidney+journal&rft.au=Wong%2C+Michelle+M+Y&rft.au=Tu%2C+Charlotte&rft.au=Li%2C+Yun&rft.au=Perlman%2C+Rachel+L&rft.date=2020-08-01&rft.pub=Oxford+University+Press&rft.issn=2048-8505&rft.eissn=2048-8513&rft.volume=13&rft.issue=4&rft.spage=613&rft.epage=624&rft_id=info:doi/10.1093%2Fckj%2Fsfz091&rft_id=info%3Apmid%2F32905241&rft.externalDocID=PMC7467578
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2048-8513&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2048-8513&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2048-8513&client=summon